The diagnostic telomere testing tool developed by Profs: Fegan, Baird and Pepper at Cardiff University has been selected as a finalist in the 2018 Innovation and Impact Awards .
Innovation award for diagnostic cancer technology
read article cardiff.ac.uk/news/view/119...
We all know that patients diagnosed with CLL may have to spend many years of emotional and psychological stress while waiting to find out if their cancer will progress. This innovative tool will help identify those never likely to require treatment and those most likely to respond to certain types of treatment. This tool can stratify patients early into appropriate treatment pathways and help inform decision making by both patients and their treating physicians.
The peoples vote is open here cardiff.ac.uk/news/view/119... until 12:00 on Friday 22 June.